We are live on ! Find out more
CHRS icon

Coherus Oncology
CHRS

201 hedge funds and large institutions have $1.23B invested in Coherus Oncology in 2021 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 53 increasing their positions, 73 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

77% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 22

57% more call options, than puts

Call options by funds: $1.14M | Put options by funds: $726K

7% more funds holding

Funds holding: 187 → 201 (+14)

0.51% more ownership

Funds ownership: 99.53% → 100.03% (+0.51%)

0% more capital invested

Capital invested by funds: $1.22B → $1.23B (+$2.59M)

27% less repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 73

Holders
201
Holders Change
+14
Holders Change %
+7.49%
% of All Funds
3.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
39
Increased
53
Reduced
73
Closed
22
Calls
$1.14M
Puts
$726K
Net Calls
+$415K
Net Calls Change
+$903K

Top Buyers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
+$19.6M
2
SCM
Suvretta Capital Management
New York
+$12.8M
3
PA
Perceptive Advisors
New York
+$11M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$5.78M
5
BlackRock
BlackRock
New York
+$5.75M

Top Sellers

Rank Fund Capital Flow
1
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$14.4M
2
JP Morgan Chase
JP Morgan Chase
New York
-$8.41M
3
Deutsche Bank
Deutsche Bank
Germany
-$4.64M
4
DGI
Disciplined Growth Investors
Minnesota
-$3.82M
5
State Street
State Street
Massachusetts
-$3.72M
Name Holding Trade Value Shares
Change 		Change in
Stake
PIM
26
Platinum Investment Management
Australia
$8.54M -$707K -40,402 -7%
Principal Financial Group
27
Principal Financial Group
Iowa
$8.29M -$2.16M -123,670 -19%
PFC
28
Phocas Financial Corp
California
$8.21M +$166K +9,502 +2%
Charles Schwab
29
Charles Schwab
California
$7.58M +$138K +7,879 +2%
FAM
30
Fred Alger Management
New York
$6.96M +$65.6K +3,754 +0.9%
Macquarie Group
31
Macquarie Group
Australia
$6.88M – – –
Deutsche Bank
32
Deutsche Bank
Germany
$6.71M -$4.64M -265,132 -39%
Morgan Stanley
33
Morgan Stanley
New York
$6.44M -$480K -27,466 -6%
EAM
34
Eagle Asset Management
Florida
$6.12M -$1.18M -67,289 -16%
Nordea Investment Management
35
Nordea Investment Management
Sweden
$5.9M +$25.7K +1,472 +0.4%
Millennium Management
36
Millennium Management
New York
$5.27M -$2.69M -153,584 -32%
Point72 Asset Management
37
Point72 Asset Management
Connecticut
$5.27M +$5.78M +330,300 New
Invesco
38
Invesco
Georgia
$4.92M -$1.96M -111,901 -27%
DGI
39
Disciplined Growth Investors
Minnesota
$3.77M -$3.82M -218,358 -48%
Bank of America
40
Bank of America
North Carolina
$3.29M -$989K -56,534 -22%
CS
41
Credit Suisse
Switzerland
$3.25M -$2.77M -158,580 -44%
Tudor Investment Corp
42
Tudor Investment Corp
Connecticut
$3.13M +$3.43M +196,222 New
PPA
43
Parametric Portfolio Associates
Washington
$2.94M -$274K -15,667 -8%
Rafferty Asset Management
44
Rafferty Asset Management
New York
$2.9M +$1M +57,458 +46%
PAM
45
Panagora Asset Management
Massachusetts
$2.85M +$3.13M +178,748 New
New York State Common Retirement Fund
46
New York State Common Retirement Fund
New York
$2.7M +$91.8K +5,249 +3%
UBS Group
47
UBS Group
Switzerland
$2.61M +$716K +40,930 +33%
BCC
48
Bridge City Capital
Oregon
$2.6M -$210 -12 -0%
DZ Bank
49
DZ Bank
Germany
$2.56M -$526K -30,060 -16%
PAMS
50
Pictet Asset Management (Switzerland)
Switzerland
$2.53M – – –
1
2
3 4 5

CHRS Hedge Fund Activity: Q4 2021 in Review

201 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Coherus Oncology (CHRS) for Q4 2021, worth a combined $1.23B — up 0.21% from $1.22B a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new CHRS positions and 22 closed out — a net gain of 17 holders — while 53 added to existing stakes and 73 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $19.6M. The largest seller was Bank of Montreal, cutting an estimated $14.4M.

  • 201 institutional investors held Coherus Oncology (CHRS) as of Q4 2021, up from 187 in Q3 2021.
  • Funds reported $1.23B of Coherus Oncology stock for Q4 2021, up 0.21% quarter-over-quarter.
  • 39 funds opened new Coherus Oncology positions in Q4 2021 and 22 closed out, a net change of +17 holders.
  • The largest Coherus Oncology buyer in Q4 2021 was AllianceBernstein, an estimated $19.6M added.
  • The largest Coherus Oncology seller in Q4 2021 was Bank of Montreal, an estimated $14.4M sold.

Based on aggregated 13F filings for Q4 2021.